Abbott acquisition of Alere set to close on Tuesday, October 3, 2017
- Details
- Category: Abbott
Abbott (NYSE: ABT) intends to close the acquisition of Alere, Inc., on Tuesday, Oct. 3, 2017. The announcement follows receipt of all regulatory clearances necessary for closing. The transaction establishes Abbott as the global leader in point of care testing - the fastest-growing segment of the $50 billion in vitro diagnostics market - and further strengthens the company's diagnostics presence.
IDF and Novo Nordisk launch first-ever global survey on cardiovascular disease awareness among people with type 2 diabetes
- Details
- Category: Novo Nordisk
To mark World Heart Day today, the International Diabetes Federation (IDF) has partnered with Novo Nordisk to launch the first-ever multi-country online survey investigating the level of CVD awareness and knowledge among people living with type 2 diabetes. The global survey - Taking Diabetes to Heart - is available in multiple languages until March 2018, and people with type 2 diabetes are encouraged to participate.
Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets
- Details
- Category: Novartis
Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered "undruggable."
Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in China
- Details
- Category: Amgen
Amgen (NASDAQ: AMGN) and Simcere Pharmaceutical Group have announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. The collaboration includes undisclosed biosimilars in the areas of inflammation and oncology.
Up to $20,000 available to the digital health company that solves one of the challenges proposed by MSD
- Details
- Category: Business
MSD is looking for innovators to solve 7 health-related challenges aiming to support physician education or patient disease management. The 3 digital solutions with the most outstanding value will receive up to $20,000 each to be launched in a local market. MSD will also work side by side with the winning solvers to facilitate the roll-out of their solution.
Daiichi Sankyo announces TaNeDS Global 2018 collaborative drug discovery program
- Details
- Category: Daiichi Sankyo
Daiichi Sankyo Company, Limited today announced details of the application for its Take a New Challenge for Drug Discovery (TaNeDS) Global 2018, a collaborative drug discovery initiative for universities and research institutes in Europe and the East Coast of the United States.
Bevespi Aerosphere demonstrates statistically significant improvement in lung function in patients with COPD
- Details
- Category: AstraZeneca
AstraZeneca today announced positive top-line results of the Phase III, PINNACLE 4 trial in which Bevespi Aerosphere* (glycopyrronium and formoterol fumarate 14.4/9.6 µg) demonstrated a statistically significant improvement in lung function as measured by trough forced expiratory volume in one second (FEV1), compared to its monotherapy components (glycopyrronium 14.4 µg and formoterol fumarate 9.6 µg) and placebo,
More Pharma News ...
- Amgen Foundation pledges up to $5 million to Hurricane Maria relief efforts
- AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors
- Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
- New scholarships worth EUR 417,000 awarded by Bayer Foundation to promote international talents
- Pfizer goes to Court to allow competition for biologics and expand options for patients
- IPF World Week 2017: Boehringer Ingelheim helps healthcare professionals to 'listen for the sounds of IPF'
- Johnson & Johnson announces collaboration with U.S. Department of Health and Human Services to fight influenza